Home/Filings/4/0001567619-22-015307
4//SEC Filing

Stanker James H 4

Accession 0001567619-22-015307

CIK 0001533743other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:28 PM ET

Size

6.1 KB

Accession

0001567619-22-015307

Insider Transaction Report

Form 4
Period: 2022-08-05
Stanker James H
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-08-05+7,60151,712 total
  • Tax Payment

    Common Stock

    2022-08-05$3.17/sh2,462$7,80549,250 total
Footnotes (1)
  • [F1]Vesting of time-based restricted shares.

Documents

1 file

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1
  • filerCIK 0001681718

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:28 PM ET
Size
6.1 KB